Allergan: 2Q Earnings Snapshot
DUBLIN (AP) _ Allergan PLC (AGN) on Tuesday reported a loss of $1.76 billion in its second quarter.
The Dublin-based company said it had a loss of $5.37 per share. Earnings, adjusted for non-recurring costs, came to $4.38 per share.
The results beat Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $4.34 per share.
The Botox maker posted revenue of $4.09 billion in the period, also surpassing Street forecasts. Eight analysts surveyed by Zacks expected $3.94 billion.
Allergan expects full-year revenue in the range of $15.43 billion to $15.63 billion.
Allergan shares have increased 20% since the beginning of the year, while the Standard & Poor’s 500 index has climbed 13%. The stock has dropped 14% in the last 12 months.